30 results match your criteria: "St.Sacrement Hospital[Affiliation]"
J Clin Microbiol
December 2000
Research Center in Infectious Diseases of the Centre Hospitalier Universitaire de Québec and Department of Medical Biology, St-Sacrement Hospital and Department of Medicine, Université Laval, Québec, Canada.
The performance of a commercially available qualitative PCR test for plasma (AMPLICOR CMV Test; Roche Diagnostics) and a quantitative PCR test for plasma and leukocytes (COBAS AMPLICOR CMV MONITOR Test; Roche Diagnostics) was evaluated with samples from 50 blood or marrow allogeneic transplant recipients who received short courses of sequential ganciclovir therapy (2 weeks intravenously followed by 2 weeks orally) based on a positive cytomegalovirus (CMV) pp65 antigenemia (AG) assay. The number of persons with a positive CMV test was significantly higher for leukocyte-based assays (AG, 67.5%; PCR, 62.
View Article and Find Full Text PDFBone Marrow Transplant
May 1999
St Sacrement Hospital, Laval University, Quebec City, Quebec, Canada.
Granulocyte colony-stimulating factor (G-CSF) is used in healthy donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. However, some data have recently suggested that G-CSF may induce a hypercoagulable state, prompting us to study prospectively 22 PBSC donors before and after G-CSF 5 microg/kg twice daily. We sought evidence for changes in the following parameters: platelet count, von Willebrand factor antigen (vWF:Ag) and activity (vWF activity), beta-thromboglobulin (beta-TG), platelet factor 4 (PF-4), platelet activation markers (GMP-140 and PAC-1), activated partial thromboplastin time (aPTT), prothrombin time (PT), coagulant factor VIII (FVIII:C), thrombin-antithrombin complex (TAT), prothrombin fragment 1+2 (F1+2), thrombomodulin (TM) and tissue plasminogen activator antigen (tPA:Ag) prior to G-CSF and immediately before leukapheresis.
View Article and Find Full Text PDFAnn Vasc Surg
May 1993
Department of Surgery, St. Sacrement Hospital, Laval University, Quebec, Canada.
Vasospasm associated with ergotamine is a well-known phenomenon. In this case report we present a rare drug interaction between erythromycin and ergotamine at normal doses causing lower extremity ischemia in a 36-year-old woman. Nitroprusside proved to be the treatment of choice.
View Article and Find Full Text PDFPlast Reconstr Surg
January 1992
Laboratoire de Recherche des Grands Brûlés, St. Sacrement Hospital, Quebec, P.Q., Canada.
The objective of this study was to establish a novel surgical model for the grafting of cultured epidermal sheets in mice in order to optimize studies on the behavior of these grafts. Graft-related skin immunology and wound-healing studies also would benefit from this adapted surgical approach. Adapted tie-over surgical procedures were established for mice and promptly applied.
View Article and Find Full Text PDFClin Dermatol
March 1989
Department of Laboratory Medicine, St. Sacrement Hospital, Quebec, Canada.